Are David Barrett’s Expensify (EXFY) option grants open-market share purchases?

No, the reported transactions are option awards classified as grants or other acquisitions. They are compensation-related derivative awards, not open‑market stock purchases. Barrett receives the right to buy shares at $1.75, rather than buying common shares directly in the market.

Expensify CEO receives new stock option grants

Expensify, Inc. Chief Executive Officer David Michael Barrett reported receiving two stock option awards.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

4/A

Rhea-AI Filing Summary

Expensify, Inc. Chief Executive Officer David Michael Barrett reported receiving two stock option awards. On June 23, 2026, he was granted options covering 2,031,280 shares and 63,694 shares of Class A common stock, each with a $1.75 exercise price and expirations on June 23, 2036 and June 23, 2031, respectively. Both option grants vest in 16 equal quarterly installments deemed to have begun on April 12, 2025, and one of the reported options is fully vested and currently exercisable.

Insider Trade Summary

Grant/Award: 2,094,974 shares

Grant/Award 2 txns

Insider Barrett David Michael

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	63,694	$0.00	$0.00
Grant/Award	Stock Option	2,031,280	$0.00	$0.00

Holdings After Transaction: Stock Option — 2,094,974 contracts (Direct)

Footnotes (2)

F1. The stock option, aggregated with the stock option expiring 6/23/2036 reported herein, vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025. This stock option is fully vested and currently exercisable.
F2. The stock option, aggregated with the stock option expiring 6/23/2031 reported herein, vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025.

Key Figures

Large option grant size: 2,031,280 options Second option grant size: 63,694 options Exercise price: $1.75 per share +3 more

6 metrics

Large option grant size 2,031,280 options Grant dated June 23, 2026, expiring June 23, 2036

Second option grant size 63,694 options Grant dated June 23, 2026, expiring June 23, 2031

Exercise price $1.75 per share Exercise price for both reported option grants

Options outstanding under 2036 grant 2,031,280 options Total stock options following transaction for 2036-expiring grant

Options outstanding under 2031 grant 63,694 options Total stock options following transaction for 2031-expiring grant

Vesting schedule 16 equal quarterly installments Vesting deemed to begin on April 12, 2025

Key Terms

Stock Option, Class A Common Stock, vests in 16 equal quarterly installments, currently exercisable

4 terms

Stock Option financial

"The stock option, aggregated with the stock option expiring 6/23/2036 reported herein, vests in 16 equal quarterly installments"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Class A Common Stock financial

"underlying_security_title": "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vests in 16 equal quarterly installments financial

"vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025"

currently exercisable financial

"This stock option is fully vested and currently exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Expensify (EXFY) CEO David Barrett report in this Form 4/A?

Expensify CEO David Barrett reported receiving two stock option grants. The awards cover Class A common stock and are structured as compensation, not open‑market purchases, with a fixed exercise price and long-dated expirations, aligning his incentives with future company performance.

How many Expensify (EXFY) shares are covered by David Barrett’s new options?

The reported grants cover options on 2,031,280 and 63,694 shares of Class A common stock. These option awards together provide rights over about 2.09 million shares, subject to their vesting schedules and exercise conditions described in the Form 4/A footnotes.

What is the exercise price of David Barrett’s new Expensify (EXFY) stock options?

Both stock option awards carry a $1.75 per share exercise price. This means Barrett can buy Class A common shares at $1.75 once the options are vested and exercisable, regardless of the market price at that time, for the life of each option grant.

When do David Barrett’s new Expensify (EXFY) stock options expire?

The larger stock option grant expires on June 23, 2036, and the smaller grant expires on June 23, 2031. These long expiration dates provide a multi‑year window during which vested options can be exercised, subject to the plan’s and company’s standard conditions.

How do the Expensify (EXFY) CEO’s new option grants vest?

Both grants vest in 16 equal quarterly installments deemed to have begun on April 12, 2025. This creates a four‑year vesting period. A footnote states that one of the reported stock options is already fully vested and currently exercisable as of the reporting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/26/2026 - 06:18 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barrett David Michael

(Last)

(First)

(Middle)

C/O EXPENSIFY, INC.

88 KEARNY ST, STE 1600

(Street)

SAN FRANCISCO

CALIFORNIA

94108

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Expensify, Inc. [ EXFY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/25/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$1.75	06/23/2026		A		63,694		⁽¹⁾	06/23/2031	Class A Common Stock	63,694	$0	63,694	D
Stock Option	$1.75	06/23/2026		A		2,031,280		⁽²⁾	06/23/2036	Class A Common Stock	2,031,280	$0	2,031,280	D

Explanation of Responses:

1. The stock option, aggregated with the stock option expiring 6/23/2036 reported herein, vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025. This stock option is fully vested and currently exercisable.

2. The stock option, aggregated with the stock option expiring 6/23/2031 reported herein, vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025.

Remarks:

On June 25, 2026, the Reporting Person filed a Form 4 reporting a grant of 2,094,974 stock options with an expiration date of 06/23/2036. However, as reported in this amendment, 63,694 of the stock options have an expiration date of 06/23/2031 with the remaining 2,031,280 having the originally reported expiration date.

	/s/ Ryan Schaffer, as attorney-in-fact	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR